# A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

> **NCT01370590** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 406 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Ezetimibe
- **DRUG:** Ezetimibe/atorvastatin
- **DRUG:** Placebo to atorvastatin
- **DRUG:** Placebo to ezetimibe
- **DRUG:** Placebo to ezetimibe/atorvastatin

## Key facts

- **NCT ID:** NCT01370590
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370590, "A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01370590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*